Self-Assessment of Symptoms by the Patient with Cancer: the Time is Now

Authors

  • Ana Maria Teixeira Pires Universidade Federal de São Paulo (Unifesp), Escola Paulista de Enfermagem (EPE), Programa de Pós-Graduação. São Paulo (SP), Brasil. https://orcid.org/0000-0003-4666-1122
  • Ariel Galapo Kann Hospital Alemão Oswaldo Cruz. São Paulo (SP), Brasil. https://orcid.org/0000-0002-7260-2030
  • Fabio Rodrigues Kerbauy Universidade Federal de São Paulo (Unifesp), Departamento de Medicina. São Paulo (SP), Brasil. https://orcid.org/0000-0002-2819-2783
  • Edvane Birelo Lopes De Domenico Universidade Federal de São Paulo (Unifesp), Escola Paulista de Enfermagem (EPE), Programa de Pós-Graduação. São Paulo (SP), Brasil. https://orcid.org/0000-0001-7455-1727

DOI:

https://doi.org/10.32635/2176-9745.RBC.2022v68n4.2733

Keywords:

patient reported outcome measures, antineoplastic agents, medical neoplasms, patient-centered care

Abstract

The article describes concepts and evidences based on scientific literature and opinions of professionals who work with cancer patients through a self-report instrument for signs and symptoms. PRO-CTCAE® is an instrument utilized for cancer patients care with the objective of empowering the patient in decision-making regarding the planning and monitoring of their treatment, highlighting symptoms hitherto not questioned or valued, qualifying patient and health professionals communication, reflecting global strategies goals for chronic diseases control.

Downloads

Download data is not yet available.

References

World Health Organization. WHO report on cancer: setting priorities, investing wisely and providing care for all [Internet]. Geneva: WHO; 2020 [cited 2022 May 5]. Available from: https://www.who.int/publications/i/item/9789240001299

Alcaraz KI, Wiedt TL, Daniels EC, et al. Understanding and addressing social determinants to advance cancer health equity in the United States: a blueprint for practice, research, and policy. CA Cancer J Clin. 2020;70(1):31-46. doi: https://doi.org/10.3322/caac.21586

Oldenmenger WH, Geerling JI, Mostovaya I, et al. A systematic review of the effectiveness of patient-based educational interventions to improve cancer-related pain. Cancer Treat Rev. 2018;63:96-103. doi: https://doi.org/10.1016/j.ctrv.2017.12.005

Pan American Health Organization. Innovative care for chronic conditions: organizing and delivering high quality care for chronic noncommunicable diseases in the Americas. Washington (DC): PAHO; 2013 [cited 2022 May 5]. Available from: https://www.paho.org/hq/dmdocuments/2013/PAHO-Innovate-Care-2013-Eng.pdf

Schmidt T, Valuck T, Perkins B, et al. Improving patient-reported measures in oncology: a payer call to action. J Manag Care Spec Pharm. 2021;27(1):118-26. doi: https://doi.org/10.18553/jmcp.2020.20313

Basch E, Reeve BB, Mitchell SA, et al. Development of the National Cancer Institute’s Patient-Reported Outcomes version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE). J Natl Cancer Inst. 2014;106(9):dju244 doi: https://doi.org/10.1093/jnci/dju244

Atkinson TM, Ryan SJ, Bennett AV, et al. The association between clinician-based common terminology criteria for adverse events (CTCAE) and patient-reported outcomes (PRO): a systematic review. Support Care Cancer. 2016;24(8):3669-76. doi: https://doi.org/10.1007/s00520-016-3297-9

Kluetz PG, Chingos DT, Basch EM, et al. Patient-Reported Outcomes in cancer clinical trials: measuring symptomatic adverse events with the National Cancer Institute’s Patient-Reported Outcomes version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE). Am Soc Clin Oncol Educ Book. 2016;35:67-73. doi: https://doi.org/10.1200/EDBK_159514

Budhwani S, Wodchis WP, Zimmermann C, et al. Self-management, self-management support needs and interventions in advanced cancer: a scoping review. BMJ Support Palliat Care. 2018;9(1):12-25. doi: https://doi.org/10.1136/bmjspcare-2018-001529

Kim J, Singh H, Ayalew K, et al. Use of PRO measures to inform tolerability in oncology trials: implications for clinical review, IND safety reporting, and clinical site inspections. Clin Cancer Res. 2018;24(8):1780-84. doi: https://doi.org/10.1158/1078-0432.CCR-17-2555

Wilson KA, Dowling AJ, Abdolell M, et al. Perception of quality of life by patients, partners and treating physicians. Qual Life Res. 2000;9(9):1041-52. doi: https://doi.org/10.1023/A:1016647407161

Laugsand EA, Sprangers MAG, Bjordal K, et al. Health care providers underestimate symptom intensities of cancer patients: a multicenter European study. Health Qual Life Outcomes. 2010;8:104. doi: https://doi.org/10.1186/1477-7525-8-104

Mendonza TR, Dueck AC, Bennett AV, et al. Evaluation of different recall periods for the US National Cancer Institute’s PRO-CTCAE. Clin Trials. 2017;14(3):255-63. doi: https://doi.org/10.1177/1740774517698645

Baeksted C, Pappot H, Nissen A, et al. Feasibility and acceptability of electronic symptom surveillance with clinician feedback using the Patient-Reported Outcomes version of Common Terminology Criteria for Adverse Events (PRO-CTCAE) in Danish prostate cancer patients. J Patient Rep Outcomes. 2017;1(1):1. doi: https://doi.org/10.1186/s41687-017-0005-6

Downloads

Published

2022-10-18

How to Cite

1.
Pires AMT, Kann AG, Kerbauy FR, De Domenico EBL. Self-Assessment of Symptoms by the Patient with Cancer: the Time is Now. Rev. Bras. Cancerol. [Internet]. 2022 Oct. 18 [cited 2024 Nov. 22];68(4):e-152733. Available from: https://rbc.inca.gov.br/index.php/revista/article/view/2733

Issue

Vol. 68 No. 4 (2022): Oct./Nov./Dec.

Section

OPINION

License

Os direitos morais e intelectuais dos artigos pertencem aos respectivos autores, que concedem à RBC o direito de publicação.

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

Most read articles by the same author(s)